Formulations for boosting nad+ using multiple biological pathways concurrently to overcome enzymatic degradation and improve downstream benefits
AssigneeProhealth
InventorsNicholas Bitz, Angelica S. Vrablic, Daniel C. Obegi
Life of this patent
Estimating the term…
Abstract
Orally-ingestible supplement formulations for boosting Nicotinamide adenine dinucleotide (NAD+) in a human. The formulations provide a triple boost for NAD+ that will provide a) NAD+ boosters to increase natural production, b) a source of NAD+ and c) inhibitors to keep NAD+ from being metabolized. The formulations have one of each of: 1) an NAD precursor and/or reduced NAD precursor, 2) an NAD booster, 3) a CD38 Inhibitor, and 4) Reduced NAD precursors.
Claims19
An orally-ingestible formulation for boosting NAD+ in a human by combining 3 or more different ingredients that use at least 3 distinct metabolic pathways selected from the group consisting of the following:
- a. a NAD precursor,
- b. a NAD booster,
- c. a CD38 Inhibitor, and
- d. a Reduced NAD precursor.
Dependencies are inferred from the claim text.